Skip to main content
. 2024 Jul 6;12(7):747. doi: 10.3390/vaccines12070747

Table 1.

Study characteristics of included studies.

Variables Category Frequency Percentage
Year of publication 2022 320 58.82%
2023 224 41.18%
Study setting Web-based 384 70.59%
In-person survey 77 14.15%
Hybrid 45 8.27%
Telephone-based survey 38 6.99%
Study design Cross-sectional survey 399 73.35%
Mixed method design 44 8.09%
Qualitative studies 37 6.80%
Longitudinal studies 42 7.72%
Miscellaneous * 22 4.04%
Population U.S. adults 176 32.35%
Ethnic and racial minority populations 80 14.71%
Healthcare workers 65 11.95%
People with specific medical conditions 53 9.74%
U.S. parents 39 7.17%
University population 25 4.60%
Pregnant or postpartum women 23 4.23%
Age-specific studies 21 3.86%
Occupational population 16 2.94%
Unvaccinated U.S. adults 14 2.57%
Military personnel 11 2.02%
Social services populations 6 1.10%
Gender-specific populations 5 0.92%
Inmate population 3 0.55%
People positive for COVID-19 3 0.55%
Low- and middle-income U.S. adults 3 0.55%
Religious or faith-based populations 1 0.18%
Sample size range 0–100 75 13.79%
101–500 155 28.49%
501–1000 82 15.07%
1001–5000 144 26.47%
5001–10,000 21 3.86%
10,001–50,000 35 6.43%
50,001–100,000 10 1.84%
>100,000 14 2.57%
N/A 8 1.47%

* Observational, ecological, descriptive studies.